iShares Nasdaq Biotechnology ETF (IBB)
| 321.65 Data as of Jan 30 |  -1.20 / -0.37%Today’s Change | 207.48 Today|||52-Week Range 329.20 | +6.03% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.
Latest IBB News
| IShares Nasdaq Biotechnology ETF Experiences Big Outflow Jan 28 / TheStreet.com | 4 Tips For Trading Biotech Stocks Jan 12 / StockTwits |
| Don’t Fight The Liquidity Jan 22 / StockTwits | VIDEO: 3 Sectors Showing Strength Jan 10 / StockTwits |
| VIDEO: 2 Minute Market Recap Jan 14 / StockTwits | VIDEO: 2 Minute Market Recap Jan 07 / StockTwits |
Performance
| 1 month | +5.63% | 3 years | +40.97% | |
| 3 months | +8.38% | 5 years | +31.34% | |
| 1 year | +28.88% | Since inception | +8.86% |
Data through 01/31/2015
Quote Details
| Previous close | $322.85 |
| Open day’s range | 321.06 – 329.16 |
| Net asset value (NAV) | 321.50 (01/30/2015) |
| Daily volume | 1,688,555 |
| Average volume (3 months) | 1,412,074 |
Data as of 4:00pm ET, 01/30/2015
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +31.34% | +22.29% |
| Expense Gross exp ratio | 0.48% | 0.44% |
| Risk 5 year sharpe ratio | 1.56 | 1.44 |
| Net assets | $6.9B | $1.5B |
| Average market cap | $17.0B | $34.2B |
| Average P/E | 33.1 | 25.1 |
| Dividend / Share | -- | 0.21% |
Competitors
| XLV Health Care Select Sector SPDR® Fund |
| RYH Guggenheim S&P 500® Equal Weight Health... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| BIIB Biogen Idec Inc | 8.77% |
| CELG Celgene Corp | 7.83% |
| AMGN Amgen Inc | 7.66% |
| GILD Gilead Sciences Inc | 7.47% |
| REGN Regeneron Pharmaceuticals Inc | 6.55% |
| VRTX Vertex Pharmaceuticals Inc | 4.01% |
| ILMN Illumina Inc | 3.85% |
| ALXN Alexion Pharmaceuticals Inc | 3.78% |
| MYL Mylan Inc | 3.61% |
| BMRN Biomarin Pharmaceutical Inc | 2.28% |
.